These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21898992)

  • 1. [Changes in prostatic stromal composition and benign prostatic hyperplasia].
    Shen W; Mao XM; Lü J; Yao HQ; Deng ZX; Zhao YB; Liu J; Hua W; Wang BQ; Hu WL
    Zhonghua Nan Ke Xue; 2011 Aug; 17(8):703-6. PubMed ID: 21898992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
    Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
    Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arteriosclerotic risk factors and benign prostatic hyperplasia].
    Shen W; Yao HQ; Deng ZX; Zhang XM; Zhang LC; Hu WL
    Zhonghua Nan Ke Xue; 2010 Jan; 16(1):29-33. PubMed ID: 20180401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative proportions of tissue components in the prostate: are they related to the development of symptomatic BPH in Korean men?
    Byun SS; Jeong H; Jo MK; Lee E
    Urology; 2005 Sep; 66(3):593-6. PubMed ID: 16140084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Applying bladder outlet obstruction number to predict bladder outlet obstruction of benign prostatic hyperplasia].
    Zhang P; Wu ZJ; Yang Y; Zhang XD
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1156-9. PubMed ID: 19094679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between expression of α₁-adrenoceptor subtype mRNA and severity of lower urinary tract symptoms or bladder outlet obstruction in benign prostatic hyperplasia patients.
    Kojima Y; Sasaki S; Imura M; Kubota Y; Hayashi Y; Kohri K
    BJU Int; 2011 Feb; 107(3):438-42. PubMed ID: 20804477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostatic middle lobe hyperplasia correlates with bladder outflow obstruction: analysis of 131 cases].
    Shen H; Zhou HT; Wu HF; Yu HB; Li BJ; Zhang B; Lin JZ
    Zhonghua Nan Ke Xue; 2011 Jun; 17(6):527-30. PubMed ID: 21735652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls.
    Inui E; Ochiai A; Naya Y; Ukimura O; Kojima M
    J Urol; 1999 Mar; 161(3):827-30. PubMed ID: 10022694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple factors related to detrusor overactivity in Chinese patients with benign prostate hyperplasia.
    Liu N; Man LB; He F; Huang GL; Wang H; Li GZ; Wang JW; Lü YW
    Chin Med J (Engl); 2012 Nov; 125(21):3778-81. PubMed ID: 23106872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
    Roehrborn CG; Nickel JC; Andriole GL; Gagnier RP; Black L; Wilson TH; Rittmaster RS
    Urology; 2011 Sep; 78(3):641-6. PubMed ID: 21764428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume].
    Qiu MX; Wang D; Wu HM; Xiong GB; Chen ZX
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1852-3. PubMed ID: 17922999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
    Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
    BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of benign prostatic hyperplasia with hyperlipemia].
    Li PJ; Zhang XH; Guo LJ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):387-9. PubMed ID: 15854349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.